technology of cryptocurrency Featured snippets

Market News: Lotte Chemical will suspend the Johor plant to reduce losses.Guangdong: In the next five years, 10 billion yuan will be invested to support the development of the tourism industry. On December 12th, a site meeting was held to promote the implementation of the spirit of the provincial tourism development conference in Guangdong. The meeting proposed to promote the implementation of the "three hundred" plan for cultural tourism investment, that is, to promote 100 major projects under construction and 100 key investment projects, to coordinate provincial financial investment of 10 billion yuan to support the development of tourism industry in the next five years, and to accelerate the implementation of the list of 100 major projects under construction and 100 key investment projects. According to the deployment, Guangdong will focus on promoting the implementation of the "three hundred" plan for cultural tourism investment and establishing "three lists" for key cultural tourism projects (namely, the list of projects under construction, the list of investment projects and the list of projects supported by financial funds). According to statistics, there are 103 major cultural tourism projects under construction in Guangdong province, with a total investment of 282.6 billion yuan, and the accumulated investment has reached 74 billion yuan by the third quarter.The compound annual growth rate of average daily turnover is 30%. The ETF market in Hong Kong is growing rapidly. The compound annual growth rate of average daily turnover in the past five years is as high as 30%, and the average daily turnover in the first 11 months of this year reached HK$ 18.7 billion. According to HKEx, Hong Kong ETF market will continue to innovate and expand with diversified product selection, market structure optimization and international cooperation.

Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Huatong Co., Ltd.: The sales revenue of live pigs in November was 410 million yuan. Huatong Co., Ltd. announced that in November 2024, the company sold 201,000 pigs, including 10,600 piglets. The sales revenue of live pigs reached 410 million yuan, an increase of 20.56% from the previous month. The average selling price of commercial pigs was 16.5 yuan/kg, down 4.07% from October. In addition, the number of chickens sold in November was 1,205,900, a decrease of 47.69% from the previous month and a year-on-year increase of 19.79%. Chicken sales revenue was 20,213,700 yuan, an increase of 23.65% from the previous month. Sales data are unaudited for investors' reference.In the first three quarters, China's total cargo transportation was 41.63 billion tons, up 2.3% year-on-year. The China Federation of Logistics and Purchasing released the China Road Freight Development Report (2023-2024) today (13th). According to the report, due to the adjustment of transportation structure, although the proportion of road transportation in China has declined, it is still the main body of the freight market, and road freight has maintained steady growth. According to the report, in the first three quarters of this year, China's total cargo transportation was 41.63 billion tons, up 2.3% year-on-year. From the perspective of freight structure, the proportion of freight undertaken by railway and waterway transportation has increased, while the proportion of road transportation has decreased. In the first three quarters, the volume of road freight transport was 30.66 billion tons, up 3.1% year-on-year, accounting for more than 73%. Road transport is still the main body of the freight market. (CCTV News)

Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.Fu Bao Information: The spot price of lithium carbonate is temporarily stable. Today, the battery-grade lithium carbonate in Fu Bao reported 75,750 yuan/ton. According to the data released by Fu Bao Lithium Power Network, the spot basis index of electric carbon is -660 yuan/ton (flat); Battery-grade lithium carbonate reported 75,500 yuan/ton (-250 yuan/ton); Industrial grade lithium carbonate (comprehensive) reported 73,500 yuan/ton (flat); The average price of battery-grade lithium carbonate is 75,750 yuan/ton (-100 yuan/ton); Lithium hydroxide index reported 70,677 yuan/ton (flat); Spodumene (SC5% in Africa) reported 535 USD/ton (flat); Spodumene (China CIF6%) reported $810/ton (flat); The spodumene index (5%≤Li2O<6%) was reported as 5750 yuan/ton (flat); The lepidolite index (2%≤Li2O<4%) was reported at 2150 yuan/ton (flat); Bauxite (7%≤Li2O<8%) is reported at 8540 yuan/ton (flat); Lithium-rich aluminum electrolyte index reported 2135 yuan/ton (flat); Fu Bao brine (lithium sulfate) discount coefficient reported 76% (flat).Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.